These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33770103)

  • 1. Pre-clinical left ventricular myocardial remodeling in patients with Friedreich's ataxia: A cardiac MRI study.
    Takazaki KAG; Quinaglia T; Venancio TD; Martinez ARM; Shah RV; Neilan TG; Jerosch-Herold M; Coelho-Filho OR; França MC
    PLoS One; 2021; 16(3):e0246633. PubMed ID: 33770103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.
    Coelho-Filho OR; Shah R; Lavagnoli CFR; Barros JC; Neilan TG; Murthy VL; de Oliveira PPM; Souza JRM; de Oliveira Severino ESB; de Souza Vilarinho KA; da Mota Silveira Filho L; Garcia J; Semigran MJ; Coelho OR; Jerosch-Herold M; Petrucci O
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):15-24. PubMed ID: 27437924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.
    Wang S; Hu H; Lu M; Sirajuddin A; Li J; An J; Chen X; Yin G; Lan T; Dai L; Zhang Y; Yin X; Song L; Dang A; Kellman P; Arai AE; Zhao S
    Eur Radiol; 2017 Nov; 27(11):4620-4630. PubMed ID: 28439652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.
    Kwiecinski J; Lennen RJ; Gray GA; Borthwick G; Boswell L; Baker AH; Newby DE; Dweck MR; Jansen MA
    J Cardiovasc Magn Reson; 2020 Aug; 22(1):57. PubMed ID: 32758255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the effects of Friedreich ataxia on the left ventricle using T1 mapping and late gadolinium enhancement.
    Peverill RE; Lin KY; Fogel MA; Cheung MMH; Moir WS; Corben LA; Cahoon G; Delatycki MB
    PLoS One; 2024; 19(5):e0303969. PubMed ID: 38814901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.
    Coelho-Filho OR; Shah RV; Neilan TG; Mitchell R; Moreno H; Kwong R; Jerosch-Herold M
    J Am Heart Assoc; 2014 Jun; 3(3):e000790. PubMed ID: 24965024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
    Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance.
    Liu B; Neil DAH; Premchand M; Bhabra M; Patel R; Barker T; Nikolaidis N; Billing JS; Treibel TA; Moon JC; González A; Hodson J; Edwards NC; Steeds RP
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):86. PubMed ID: 33308240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
    Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction.
    St John Sutton M; Ky B; Regner SR; Schadt K; Plappert T; He J; D'Souza B; Lynch DR
    Echocardiography; 2014; 31(1):50-7. PubMed ID: 23834395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study.
    Kim HM; Kim HK; Lee JH; Lee YB; Park EA; Park JB; Lee SP; Kim YJ; Kim YJ; Yoon JH; Sohn DW
    J Cardiovasc Magn Reson; 2020 Apr; 22(1):25. PubMed ID: 32321533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.